Evidence for post-transcriptional regulation of interleukin-5 by dexamethasone

Immunology

Volumn 109, Issue 4, 2003, Pages 527-535

  Staples, Karl J ^a,b   Bergmann, Martin W ^a,c   Barnes, Peter J ^a   Newton, Robert ^a,d  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DEXAMETHASONE; INTERLEUKIN 5; LUCIFERASE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH2 CELL; TRANSCRIPTION REGULATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; DACTINOMYCIN; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; LUCIFERASES; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0042769826     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01679.x     Document Type: Article

References (48)

1. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
2. Clutterbuck EJ, Hirst EM, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GMCSF. Blood 1989; 73:1504-12.
3. Ema H, Suda T, Nagayoshi K, Miura Y, Civin CI, Nakauchi H. Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils. Blood 1990; 76:1956-61.
4. Humbert M, Corrigan CJ, Kimmitt P, Till SJ, Kay AB, Durham SR. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997; 156:704-8.
5. Hamid Q, Azzawi M, Ying S. et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87:1541-6.
6. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12:477-87.
7. Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999; 51:213-340.
8. Shichijo M, Inagaki N, Kimata M, Serizawa I, Saito H, Nagai H. Role of cyclic 3′5′-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells. J Allergy Clin Immunol 1999; 103:S421-S428.
9. Salvi S, Semper A, Blomberg A. et al. Interleukin-5 production by human airway epithelial cells. Am J Respir Cell Mol Biol 1999; 20:984-91.
10. National Asthma Education and Prevention Program. NIH Publication 97-4051. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. Bethesda MD: National Institutes of Health, National Heart, Lung and Blood Institute, 1997.
11. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157:S1-53.
12. Beato M. Gene regulation by steroid hormones. Cell 1989; 56:335-44.
13. Dahlman-Wright K, Wright A, Gustafsson JA, Carlstedt-Duke J. Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 1991; 266:3107-12.
14. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000; 55:603-13.
15. Rolfe FG, Hughes JM, Armour CL, Sewell WA. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 1992; 77:494-9.
16. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, Durham SR, Kay AB. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis 1993; 147:540-7.
17. Cato AC, Wade E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996; 18:371-8.
18. Barnes PJ, Karin M. Nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-71.
19. Karlen S, D'Ercole M, Sanderson CJ. Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0. Blood 1996; 88:211-21.
20. Peppel K, Vinci JM, Baglioni C. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 1991; 173:349-55.
21. Han J, Brown T, Beutler B. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990; 171:971-2]. J Exp Med 1990; 171:465-75.
22. Staples KJ, Bergmann M, Barnes PJ, Newton R. Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action. Biochem Biophys Res Commun 2000; 273:811-15.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
24. Newton R, Kuitert LM, Slater DM, Adcock I, Barnes PJ. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci 1997; 60:67-78.
25. Bourke PFLB, Campbell HD, Young IG. Localization of the inducible enhancer in the mouse interleukin-5 gene that is responsive to T-cell receptor stimulation. Blood 1995; 85:2069-77.
26. Stranick KS, Zambas DN, Uss AS, Egan RW, Billah MM, Umland SP. Identification of transcription factor binding sites important in the regulation of the human interleukin-5 gene. J Biol Chem 1997; 272:16453-65.
27. Mori A, Kaminuma O, Mikami T, Hoshino A, Ohmura T, Miyazawa K, Suko M, Okudaira H. Dissection of human IL-5 promoter - essential role of CLEO element in human IL-5 gene transcription. Int Arch Allergy Immunol 1997; 113:272-4.
28. Rolfe FG, Valentine JE, Sewell WA. Cyclosporin A and FK506 reduce interleukin-5 mRNA abundance by inhibiting gene transcription. Am J Respir Cell Mol Biol 1997; 17:243-50.
29. Mori A, Kaminuma O, Mikami T, Inoue S, Okumura Y, Akiyama K, Okudaira H. Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. J Allergy Clin Immunol 1999; 103:S429-36.
30. Ogawa K, Kaminuma O, Kikkawa H, Akiyama K, Mori A. IL-5 synthesis by T cells of allergic subjects is regulated at the transcriptional level. Int Arch Allergy Immunol 2000; 122(Suppl. 1):63-6.
31. Mori A, Kaminuma O, Suko M. et al. Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids. Blood 1997; 89:2891-900.
32. Blumenthal SG, Aichele G, Wirth T, Czernilofsky AP, Nordheim A. Dittmer J. Regulation of the human interleukin-5 promoter by ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1. J Biol Chem 1999; 274:12910-16.
33. Lee HJ, O'Garra A, Arai K, Arai N. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-binding protein. J Immunol 1998; 160:2343-52.
34. Gruart-Gouilleux V, Engels P, Sullivan M. Characterization of the human interteukin-5 gene promoter: involvement of octamer binding sites in the gene promoter activity. Eur J Immunol 1995; 25:1431-5.
35. Stranick KS, Uss AS, Zambas DN, Egan RW, Billah MM, Umland SP. Characterization of the mouse interleukin-5 promoter in a mouse TH2 T cell clone. Biochem Biophys Res Commun 1998; 252:56-62.
36. Tsuruta L, Lee HJ, Masuda ES, Yokota T, Arai N, Arai K. Regulation of expression of the IL-2 and IL-5 genes and the role of proteins related to nuclear factor of activated T cells. J Allergy Clin Immunol 1995; 96:1126-35.
37. Lindstein T, June CH, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244:339-43.
38. Umland SP, Razac S, Shah H, Nahrebne DK, Egan RW, Billah MM. Interleukin-5 mRNA stability in human T cells is regulated differently than interleukin-2, interleukin-3, interleukin-4, granulocyte/macrophage colony-stimulating factor, and interferon-gamma. Am J Respir Cell Mol Biol 1998; 18:631-42.
39. Thomas MA, Karlen S, D'Ercole M, Sanderson CJ. Analysis of the 5′ and 3′UTRs in the post-transcriptional regulation of the interleukin-5 gene. Biochim Biophys Acta 1999; 1444:61-8.
40. Shaw G, Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46:659-67.
41. Jarzembowski JA, Rajagopalan LE, Shin HC, Malter JS. The 5′-untranslated region of GM-CSF mRNA suppresses translational repression mediated by the 3′ adenosine-uridine-rich element and the poly (A) tail. Nucleic Acids Res 1999; 27:3660-6.
42. van der Westhuizen FH, Pretorius PJ, de Wet WJ. Contribution of regions 3′ and 5′ to the hIL-5 gene on the expression of rhIL-5 in CHO-cells. Biochem Biophys Res Commun 1996; 227:576-80.
43. Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 4 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000; 20:6891-903.
44. Buzby JS, Brewer G, Nugent DJ. Developmental regulation of RNA transcript destabilization by A + U-rich elements is AUF1-dependent. J Biol Chem 1999; 274:33973-8.
45. Carballo E, Lai WS, Blackshear PJ. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 2000; 95:1891-9.
46. Lai WS, Stumpo DJ, Blackshear PJ. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem 1990; 265:16556-63.
47. Peng SS, Chen CY, Xu N, Shyu AB. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 1998; 17:3461-70.
48. Raghavan A, Robison RL, McNabb J, Miller CR, Williams DA, Bohjanen PR. HuA and Tristetraprolin are induced following T cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem 2001; 276:47958-65.